{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.65","upperLimit":"5.47","value":"3.06"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"196"}],"units":"Participants"}],"description":"Percentage of Arm D patients experiencing grade 4+ adverse events.","dispersionType":"95% Confidence Interval","groups":[{"description":"Intermediate \\& High Risk; Neoadjuvant chemoradiotherapy","id":"OG000","title":"Arm D"}],"paramType":"NUMBER","populationDescription":"Excluding ineligible patients and patients not treated based on the protocol.","reportingStatus":"POSTED","timeFrame":"13 weeks","title":"Toxicity Rate","type":"SECONDARY","unitOfMeasure":"percentage of participants"}